The role of the CPNKEKEC sequence in the β2 subunit I domain in regulation of integrin αLβ2 (LFA-1)

Journal of Immunology

Volumn 168, Issue 5, 2002, Pages 2296-2301

  Kamata, Tetsuji ^a   Tieu, Kenneth Khiem ^a   Tarui, Takehiko ^a   Puzon McLaughlin, Wilma ^a   Hogg, Nancy ^a   Takada, Yoshikazu ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYSTEINYLPROLYLASPARAGINYLLYSYLGLUTAMINYLLYSYLCYSTEINE; EPITOPE; GLUTAMINE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MANGANESE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALPHA CHAIN; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BETA CHAIN; CONFORMATIONAL TRANSITION; DISULFIDE BOND; GENE DELETION; LIGAND BINDING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 0036499161     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.5.2296     Document Type: Article

References (43)

1. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
2. Regulation of leukocyte integrin function: Affinity vs. avidity
3. Ins and outs of LFA-1
4. The leukocyte integrins
5. The dynamic regulation of integrin adhesiveness
6. 2+ binding epitope on leukocyte integrin α subunits
7. Divalent cation regulation of the function of the leukocyte integrin LFA-1
8. Early events of the immune response mediated by leukocyte integrins
9. Interaction of leukocyte integrins with ligand is necessary but not sufficient for function
10. 2) integrin
11. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18)
12. Two conformations of the integrin A-domain (I-domain): A pathway for activation?
13. 1
14. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a 1-domain
15. Computational design of an integrin I domain stabilized in the open high affinity conformation
16. 2 I domain with disulfide bonds reveals functional relationships among integrin domains
17. 2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond
18. 3
19. 3 integrins by swapping a short diverse sequence of the β subunit
20. 3
21. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit
22. Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA-2 and LFA-3
23. Monoclonal antibodies against human leucocyte antigens. IV. Antibodies against subunits of the LFA-1 (CD11a/CD18) leukocyte-adhesion glycoprotein
24. Expression of T cell antigen receptor heterodimers in a lipid-linked form
25. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site
26. 2 integrins for interactions with ICAM-1 and C3bi
27. The properdin-like type I repeats of human thrombospondin contain a cell attachment site
28. 2, CD11b/CD18)
29. 2 ligand interactions
30. 1 to fibronectin and invasin but not recruitment to adhesion plaques
31. 1 subunit
32. Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1)
33. 2 integrin lymphocyte function associated antigen-1 contains a binding site for ligand intercellular adhesion molecule-1
34. 2 integrin lymphocyte function-associated antigen-1
35. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1)
36. Point mutations impairing cell surface expression of the common β subunit (CD18) in a patient with leukocyte adhesion molecule (Leu-CAM) deficiency
37. 2+
38. 1 in human platelets
39. Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations
40. 3 and elicit different functional responses
41. 5 subunits contain a metal ion-dependent adhesion site-like motif but lack an I domain
42. 1 subunit using activating and inhibiting antibodies
43. 2 subunit: A model for the I-domain